|Bid||5.61 x 800|
|Ask||5.78 x 800|
|Day's Range||5.39 - 5.79|
|52 Week Range||4.07 - 36.37|
|Beta (5Y Monthly)||1.17|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 21, 2023 - Feb 27, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||13.07|
Subscribe to Yahoo Finance Plus to view Fair Value for LUNG
REDWOOD CITY, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the 34th Annual Piper Sandler Healthcare Conference in New York on Wednesday, November 30, 2022, at 11:30 AM PT / 2:30 PM ET. A live and archived webcast of the presentation will be available on “Investors” section of the Pulmonx website at https://i
Market forces rained on the parade of Pulmonx Corporation ( NASDAQ:LUNG ) shareholders today, when the analysts...
Pulmonx ( NASDAQ:LUNG ) Third Quarter 2022 Results Key Financial Results Revenue: US$13.5m (up 1.8% from 3Q 2021). Net...